The findings of a recent study challenge the hypothesis that schizophrenia and other cognitive impairments are associated with GABA deficiency. The study compared the brain chemistry of schizophrenia...
In a new study, researchers aimed to determine the effects of a diabetes drug added to clozapine or olanzapine treatment for schizophrenia. To see the results, including how the drug affected...
Aristada recently received approval from the US Food and Drug Administration for a new and shorter dosing regimen, providing more options to patients and health care providers.
The American Society of Addiction Medicine has issued a consensus document to guide the appropriate use of drug testing in patients with or at risk for addiction.
In a large-scale meta-analysis, researchers analyzed the prevalence and incidence of cardiovascular diseases and cardiovascular-related death in patients with severe mental illness and the general...
In the year following a new psychosis diagnosis, the death rate for young people is 24 times higher than for young people without psychosis, according to a new study published online in Schizophrenia...
An exaggerated emotional brain response to nonthreatening, nonemotional cues at age 14 predicted the onset of psychosis symptoms within the next 2 years.
Researchers evaluated data from acute respiratory distress syndrome patients to see if it was possible to anticipate which ones would develop psychiatric symptoms.
